GE Healthcare Archives - Medical Design Sourcing

GE HealthCare launches ‘new era’ of AI-enhanced oncology solutions

GE HealthCare (Nasdaq: GEHC) + today announced the launch of its “new era” of AI-enhanced oncology solutions, known as Revolution RT.

Revolution RT is a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to increase imaging accuracy and simplify simulation workflow. The Chicago-based company designed the technology to create a more personalized and seamless oncology care pathway experience for clinicians and patients. The technology was showcased at the European Society for Therapeutic Radiology and Oncology 2024 Congress in Glasgow, Scotland.

The company also launched an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy Platform (iRT) that interfaces with the Spectronic magnetic resonance imaging Planner.

“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-dri…

FDA clears new patient monitor from GE HealthCare

The Portrait VSM vital signs monitor. [Image courtesy of GE HealthCare]GE HealthCare (Nasdaq: GEHC) + announced today that it received FDA 510(k) clearance for its Portrait VSM vital signs monitor.

Portrait VSM provides clinicians with an accurate view of patient vital signs to support timely clinical decisions. It utilizes the SuperSTAT non-invasive blood pressure algorithm to provide precise and accurate measurement readings. Through wireless connectivity and seamless EMR integration, the monitor centers around workflow efficiency. It offers customized early warning scores (EWS) and enables care teams to focus on patient care by automating routine tasks.

The system builds on the GE HealthCare family of Portrait monitoring solutions. It can connect with the latest iteration of the Portrait Mobile wireless, wearable continuous monitoring system as well. Using a single click of a barcode scanner, Portrait VSM automatically…

GE HealthCare adds MIM Software to Elekta collaboration

GE HealthCare (Nasdaq: GEHC) + announced today that it expanded its relationship with Elekta with more collaboration on software for radiation oncology.

Together, the companies aim to accelerate innovation in software to improve workflows, increase throughput and enhance user experience. They expect to enable greater precision in radiation therapy treatment with less time at the hospital for patients.

It builds on a collaboration between GE HealthCare and Elekta first announced just over two years ago. The latest expansion adds in MIM Software, which GE HealthCare acquired just weeks ago. MIM Software provides AI-based software for radiation oncology, molecular radiotherapy, diagnostic imaging and urology.

“Our decision to join GE HealthCare was driven by a ‘shared vision of maximizing impact’ and our motivation for this collaboration with Elekta is no different,” said Andy Nelson, CEO of MIM Software, GE Health…

GE HealthCare launches new AI-enhanced ultrasound for women’s health

The Voluson Signature 20 system. [Image from the GE HealthCare website]GE HealthCare (Nasdaq: GEHC) + announced today that it launched the Voluson Signature 20 and 18 ultrasound systems for women’s health imaging applications.

Chicago-based GE HealthCare designed the systems to integrate AI, advanced tools and an ergonomic design. They speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health. The latest systems combine high-performance hardware with flexible, scalable software to help increase confidence in diagnostic and treatment decisions.

The company said in a news release that AI-enabled ultrasound technologies support clear, quick and confident diagnoses. This latest launch helps to address patient demand and reduce staffing burdens by giving clinicians these tools. Dr. Ben Csapo, a maternal fetal medicine specialist in Graz, Austria, said AI enable…

GE HealthCare, Nvidia team up to bring AI to ultrasound

GE HealthCare (Nasdaq: GEHC) + announced that it utilized Nvidia technology to develop an AI-powered research model called SonoSAMTrack.

SonoSAMTrack combines a promptable foundation model for segmenting objects on ultrasound images called SonoSAM. It segments anatomies, lesions and other essential areas in ultrasound images. GE HealthCare also offers a streamlined version called SonoSAMLite.

The latest development builds on a long-term AI collaboration between GE HealthCare and Nvidia. Nvidia, a leader in AI computing, has worked with a number of medtech companies to incorporate AI into their technologies. Johnson & Johnson MedTech announced this week that it plans to accelerate and scale AI for surgery in partnership with Nvidia.

Asensus Surgical linked up with Nvidia last year to deliver novel clinical intelligence to surgeons in surgical robotics. Medtronic also partnered with Nvidia to enable an AI Acce…

GE HealthCare establishes foundation to advance access to care

GE HealthCare (Nasdaq: GEHC) + today announced the formation of a philanthropic entity to focus on advancing equitable access to healthcare.

The company established the GE HealthCare Foundation as a charitable organization, incorporated separately from GE HealthCare itself. It supports nonprofit organizations hoping to make healthcare more accessible, personal, human and flexible.

Ultimately, according to a news release, the Foundation wants to remove barriers blocking underserved communities from care. Its initial focus centers on improving maternal health outcomes around the globe.

“The GE HealthCare Foundation was born out of GE HealthCare’s legacy of delivering access to care, and a desire to advance health equity by reducing the limits and barriers faced by those in underserved communities,” said Danielle Halstrom, president of the GE HealthCare Foundation. “When we looked at where we could focus the Founda…

GE HealthCare, Mass General bring AI to imaging

GE HealthCare (Nasdaq: GEHC) + announced today that it plans to expand its AI partnership with Mass General Brigham.

The two began work on AI solutions after announcing a 10-year commitment in 2017. They set out to explore AI across a broad range of diagnostic and treatment paradigms through sustainable AI development.

In September, they announced an effort to co-develop an AI algorithm to increase operations effectiveness and productivity. Today’s announcement highlights a plan to integrate medical imaging foundation model into their AI research work. The partnership also features a strong focus on responsible AI practices.

Dr. Keith Dreyer, Mass General Brigham’s chief data science officer, said the “next wave of AI innovation” already reshaped the building, integration and use of AI. Dreyer says GE HealthCare and Mass General already helped accelerate the introduction of AI into a rang…

GE Healthcare’s AI models can predict patient responses to immunotherapy

GE HealthCare (Nasdaq: GEHC) + today announced data showing its AI models’ ability to accurately predict patient responses to immunotherapies.

The study collected clinical data to accurately forecast the effectiveness and toxicity of cancer immunotherapy. Data demonstrated accuracy between 70% and 80% with the AI models in a pan-cancer cohort. Investigators published outcomes in the Journal of Clinical Oncology Clinical Cancer Informatics (JCO CCI).

According to a news release, the authors believe the approach is the first attempt to design AI model capable of assessing the risks and benefits of immunotherapy using only electronic health record (EHR) data. Inputs already exist in medical records, like diagnosis codes and medication, providing an advantage for the AI models. The study drew just two features (smoking status and number of prior immune checkpoint inhibitor (ICI) drugs) from manually collected data. Read more

GE HealthCare, Biofourmis collab on at-home patient monitoring

GE HealthCare (Nasdaq: GEHC) + announced today that it entered into a collaboration with Biofourmis to enable safe, effective, accessible care in the home.

The two companies paired up to support the patient journey beyond the hospital setting. Their collaboration leverages combined expertise in innovative care-at-home solutions. They say hospital systems face increased costs of care due to workforce shortages, shrinking bed capacity and increasing readmission rates. At-home care can support recovery and safety while potentially reducing fall risks and hospital-acquired infections.

GE HealthCare and BioFourmis want to enable more patients to go home earlier. They hope to offer an alternative to facility-based care , driving healthy behaviors by managing patients remotely. According to a news release, insights from Biofourmis’ FDA-cleared, AI-guided algorithms can help deliver that personalized care.

“…

How GLP-1s tanked and reshaped the medtech stock market in 2023

Analysts weigh in on how the GLP-1 craze caused one of the biggest swings in the medtech stock market in recent years.

[Image courtesy of Nick Chong on Unsplash]In a tumultuous year for the medtech industry, promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market, triggering one of the largest dips in market value that analysts have seen in years.

While analysts said the medtech stock market performed well in 2023 – driven by strong market growth from the backlog of procedures that built up during the pandemic and more innovation and new product launches from companies – the fear of GLP-1s prevailed among investors, sending medtech stocks down significantly in the second half of the year, even as top executives sought to allay concerns.

The specter of GLP-1s such as Novo Nordisk’s Wegovy and Ozempic loomed large, casting doubt on medtech’s future trajectory at the end of the year. However, the stocks have almost fully recovered since then. Analysts predict a rebound in 2024, with diminishing head…

GE HealthCare prices $1B offering

GE HealthCare (Nasdaq: GEHC) + announced today that it priced an underwritten public offering worth an amount totaling more than $1 billion.

Chicago-based GE HealthCare priced the offering of 13 million shares of common stock at $82.25 per share. That translates to $80.605 per share, net of underwriting discount. At the price of $82.25 per share, the total equity value of the offering reaches nearly $1.07 billion.

The company is not selling any shares of common stock and won’t receive any proceeds from the sale of shares in the offering or from its debt-for-equity exchange.

Prior to the offering’s closing, GE expects to exchange the GE HealthCare shares for indebtedness of GE held by Morgan Stanley. Following this exchange, if consummated, Morgan Stanley intends to sell the GE HealthCare shares to the offering’s underwriters.

Morgan Stanley granted the underwriters an option to purchase …

GE HealthCare, MedQuest collab on tech for outpatient imaging

GE HealthCare (Nasdaq: GEHC) + announced that it partnered with MedQuest to optimize multi-site outpatient imaging networks.

MedQuest is a leading owner, operator and manager of outpatient diagnostic imaging facilities. The three-year collaboration provides access to GE HealthCare’s technology with infrastructure and resources from MedQuest. The companies believe MedQuest’s model with GE HealthCare’s offerings can help deploy emerging imaging solutions, including those supporting theranostics, into the ambulatory setting.

“Our commitment to customer-centric care is at the center of everything we do,” said MedQuest CEO Jason Howard. “Building upon our more than 25-year history as a leader in outpatient imaging, our partnership with GE HealthCare will position us at the forefront of innovative care delivery and product line development, enhancing the level of care for our patients and health…